Post Market Clinical Follow-up Study for the Amvia/Solvia Pacemaker Family
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 129 participants.
Also called NCT06018818
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 129 participants
- Sponsor
- Registry
-
NCT06018818
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Austria, Germany
- Registry status
- Completed
Technical summary
Registry record NCT06018818. Allocation not applicable; no masking; primary purpose treatment. Start 2023-08-23 (actual); primary completion 2025-07-21 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Post Market Clinical Follow-up Study for the Amvia/Solvia Pacemaker Family
- Condition
- Bradycardia
- Condition
- Heart Failure
- Intervention (Device)
- Amvia/Solvia pacemaker family
- Lead sponsor
- Biotronik SE & Co. KG
Record details
- Record id
cardio:ct-nct06018818- Content hash
a53dae63942eadfdb4ef9b9a5dc69b90dd907d18051fc20000b56df277e573b7